AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.५५
arrow_downward
-१.१२%(-०.३४) 1D
नोभेम्बर १८, १३:४६:५८ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७७ अरब
Avg. vol.
१२.१३ लाख
Volume
१.२२ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७७ अरब
Avg. vol.
१२.१३ लाख
Volume
१.२२ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers in the Nov. 18, 2026 US Session
The Motley Fool
·
४८ मिनेट पहिले
If You'd Invested $1,000 in an S&P 500 ETF Ahead of the Dot-Com Bubble, Here's What You'd Have Today
BigGo Finance
·
६ घण्टा पहिले
UBS Sets S&P 500 End-2027 Target at 8,200, 12% Above Current Level, Assuming Continued AI Investment
StoneX
·
७ घण्टा पहिले
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc